David A. Bender, MD, is affiliated with The University of Texas at Austin Dell Medical School and Washington University School of Medicine. His publications focus on the clinical application of psychedelics in psychotherapy, particularly regarding depression (MDD). He has contributed to research on psychedelic therapies and psychological support methods used by practitioners. His work appears in Psychiatrist.com, collaborating frequently with colleagues including Baris C. Ercal and David J. Hellerstein.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
